Press Release

ASKA Pharmaceutical Holdings Participates at "2nd Femtech Tokyo"

TOKYO, September 21, 2023 - ASKA Pharmaceutical Holdings Co., Ltd. (Head Office: Minato-

ku, Tokyo/ President, Representative Director: Takashi Yamaguchi, hereinafter "ASKA"), announced that ASKA will exhibit a booth at the 2nd Femtech Tokyo to be held at Tokyo Big Sight from Thursday, October 5 to Saturday, October 7, 2023.

【Contents of the Exhibition】

ASKA Pharmaceutical Co., Ltd.

(Head Office: Minato-ku, Tokyo/ President, Representative Director: Sohta Yamaguchi)

  • "Training Videos on Women's Health" produced for people working in companies, organizations, etc.
  • "Mint ⁺ Femknowledge," a new website where companies that market Femtech-related products can advertise

ASKA Pharma Medical Co., Ltd.

(Head Office: Fujisawa-shi, Kanagawa/ President, Representative Director: Junichi Saito)

  • Mailing test kits utilizing testing technology

ASKA will continue to support women's health and corporate health management through its Femtech and testing businesses.

Dates:

Oct. 5 (Thu) - 7 (Sat), 2023 *The show opens to the public on 7th.

Venue:

East Exhibition Halls, Tokyo Big Sight, Japan

Organizer:

RX Japan Ltd.

Website:

https://www.femtech-week.jp/hub/en-gb.html

Media Contacts

ASKA Pharmaceutical Holdings Co., Ltd.

Corporate Planning Department

Tel: +81-3-5484-8366

Email: kouhou@aska-pharma.co.jp

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

ASKA Pharmaceutical Co. Ltd. published this content on 21 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 September 2023 04:49:06 UTC.